These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25130791)

  • 1. Stop adding metal layers: Will bioabsorbable scaffolds become the gold standard for late in-stent restenosis and neo-atherosclerosis?
    Kilic ID; Konstantinidis N; Pighi M; Mattesini A; Di Mario C
    Cardiovasc Revasc Med; 2015 Mar; 16(2):124-6. PubMed ID: 25130791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
    Ando H; Amano T; Takashima H; Harada K; Kitagawa K; Suzuki A; Kunimura A; Shimbo Y; Harada K; Yoshida T; Kato B; Uetani T; Kato M; Matsubara T; Kumagai S; Yoshikawa D; Isobe S; Ishii H; Murohara T
    Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):996-1001. PubMed ID: 23341147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing bioabsorbable vascular scaffold failure: combined scaffold restenosis and late-acquired coronary aneurysm treated with self-expandable stent.
    La Manna A; Mangiameli A; Capodanno D; Longo G; Sgroi C; Tamburino C
    Can J Cardiol; 2015 May; 31(5):691.e1-3. PubMed ID: 25936494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold.
    Mangiameli A; Ohno Y; Attizzani GF; Capodanno D; Tamburino C
    JACC Cardiovasc Interv; 2015 Apr; 8(4):633-4. PubMed ID: 25819179
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provisional hybrid 2-stent Strategy utilizing bioresorbable vascular scaffold and drug-eluting metal stent: "T-stenting and small protrusion" technique.
    Miyazaki T; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):682-5. PubMed ID: 25510349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trial.
    Koizumi T; Fitzgerald PJ; Honda Y; Ellis SG; Kent K; Martin SL; Brown CL; Masud AR; Patterson JB; Greenberg J; Friedman M; Uchida T; Stone GW
    Cardiovasc Revasc Med; 2010; 11(3):140-8. PubMed ID: 20599163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary graft angioplasty guided by MSCT: an unexpected ostial stent deformation.
    Pesenti Rossi D; Caussin C; Baron N; Fourme T; Livarek B
    Eur Heart J Cardiovasc Imaging; 2013 Apr; 14(4):308. PubMed ID: 23103947
    [No Abstract]   [Full Text] [Related]  

  • 9. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late target lesion revascularization following drug-eluting stents - looking back and forward to success.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):304-5. PubMed ID: 18288752
    [No Abstract]   [Full Text] [Related]  

  • 11. Paclitaxel crystals on the surface of a bioresorbable vascular scaffold visualized by optical coherence tomography after drug-eluting balloon angioplasty.
    López-Benito M; Pérez de Prado A; Cuellas C; Estévez R; Fernández-Vázquez F
    Eur Heart J Cardiovasc Imaging; 2017 Jun; 18(6):638. PubMed ID: 28329070
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.
    Ota H; Mahmoudi M; Kitabata H; Torguson R; Chen F; Satler LF; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2015 Mar; 16(2):84-9. PubMed ID: 25870152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-stent neoatherosclerosis: a final common pathway of late stent failure.
    Park SJ; Kang SJ; Virmani R; Nakano M; Ueda Y
    J Am Coll Cardiol; 2012 Jun; 59(23):2051-7. PubMed ID: 22651862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A completely fractured zotarolimus-eluting stent in an aortocoronary saphenous vein bypass graft.
    Venero CV; Aligeti VR; Wortham DC
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):62-5. PubMed ID: 22553171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Van den Branden F; Van Langenhove G;
    J Am Coll Cardiol; 2007 Jul; 50(3):261-7. PubMed ID: 17631219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very late bioresorbable vascular scaffold thrombosis due to late device recoil.
    Cortese B; Piraino D; Ielasi A; Steffenino G; Orrego PS
    Int J Cardiol; 2015; 189():132-3. PubMed ID: 25889443
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous restenosis of Taxus and Cypher drug-eluting stents.
    Nilsson KR; Gharacholou SM; Sketch MH; Krucoff MW
    J Invasive Cardiol; 2006 Nov; 18(11):557-60. PubMed ID: 17090822
    [No Abstract]   [Full Text] [Related]  

  • 19. 30-year patency of a saphenous vein graft in coronary bypass graft surgery.
    Ozcan AV; Evrengul H; Goksin I; Gur S; Kaftan A
    Ann Thorac Surg; 2008 Apr; 85(4):e23. PubMed ID: 18355484
    [No Abstract]   [Full Text] [Related]  

  • 20. Slow-flow phenomenon after Paclitaxel-coated balloon angioplasty: findings from optical coherence tomography and coronary angioscopy.
    Ikenaga H; Kurisu S; Ishibashi K; Dohi Y; Fukuda Y; Kihara Y
    JACC Cardiovasc Interv; 2015 Apr; 8(4):e59-62. PubMed ID: 25819189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.